GlassScriptPhysician profile
Pedram J Kohan
NPI 1710392840
$1,516.80
in general payments reported to CMS, 2019-2025
15 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $68.02 · 2021: $166 · 2022: $182 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.86 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.86 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $258.33 | 2019 | |
| Amgen INC. | $214.44 | 2019 | |
| Horizon Therapeutics Plc | $184.80 | 2019-2022 | |
| Lilly USA, LLC | $184.11 | 2019-2025 | Kisunla |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.87 | 2019 | |
| Hill-Rom Services, INC | $100.00 | 2019 | |
| Cranial Technologies, INC | $84.54 | 2019-2022 | |
| Novo Nordisk INC | $79.75 | 2022-2025 | Rybelsus, Ozempic |
| Dexcom, INC. | $74.66 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $38.48 | 2025 | Zoryve |
| Phadia US INC. | $19.01 | 2019 | |
| Gilead Sciences, INC. | $18.24 | 2020 | |
| Sanofi Pasteur INC. | $16.07 | 2022 | |
| Allergan, INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedram Kohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.